微RNA工程化细胞外囊泡修复烧伤创面:烧伤特异性设计与转化前景
该综述提出面向烧伤的微RNA工程化细胞外囊泡框架,将上游亲本细胞编程、下游囊泡修饰与生物材料辅助递送,同烧伤深度、焦痂、感染、缺氧、全身炎症、吸入性损伤、植皮需求及SIRS至CARS免疫失调等屏障对齐。同时讨论大面积烧伤剂量放大、重复应用、清创植皮兼容性、储运无菌及感染创面使用等转化要求,指出缺乏大动物、感染烧伤、植皮、长期瘢痕及人体安全性数据前临床转化仍属推测。
要点
- 微RNA工程化细胞外囊泡是烧伤创面修复的可调控无细胞平台。
- 设计须对齐烧伤深度、焦痂、感染、缺氧及SIRS-CARS免疫失调等屏障。
- 转化需解决大面积剂量放大、重复应用、清创植皮兼容与储运无菌。
核心结论
- 微RNA工程化细胞外囊泡是烧伤创面修复的多功能平台,但缺乏大动物、感染烧伤、植皮、长期瘢痕及人体安全性数据前,临床转化仍属推测。
研究设计与样本
- 综述提出面向烧伤的框架,整合上游亲本细胞编程、下游囊泡修饰与生物材料辅助递送。
主要发现
- 天然细胞外囊泡制备受低产量、异质性、靶向不足及货物控制不完整限制。
- 当前多数证据仍来自非烧伤创面模型。
关键数值与推荐
- 框架对齐烧伤深度、焦痂、感染、缺氧、全身炎症、吸入性损伤、植皮需求及SIRS至CARS免疫失调等屏障。
- 转化要求包括大面积烧伤剂量放大、重复应用、清创植皮兼容性、烧伤中心储运解冻、无菌、感染创面使用及局部递送能否缓解全身功能障碍。
临床怎么用
- 烧伤科应用时需按烧伤特异性屏障设计微RNA工程化细胞外囊泡,并评估与清创植皮流程的兼容性。
- 在感染创面及大面积烧伤中需关注剂量放大、重复应用与无菌储运条件。
局限性
- 缺乏大动物、感染烧伤、植皮、长期瘢痕及人体安全性数据。
- 多数现有证据来自非烧伤创面模型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Burn wound healing remains a major clinical challenge. Mesenchymal stem cell-derived extracellular vesicles engineered to deliver defined microRNA cargo or modulate endogenous microRNA profiles have emerged as promising cell-free therapeutics, but native extracellular vesicle preparations remain constrained by low yield, heterogeneity, insufficient targeting, and incomplete cargo control. Moreover, much of the current evidence still comes from non-burn wound models. This review presents a burn-oriented framework that aligns upstream parental-cell programming, downstream vesicle modification, and biomaterial-assisted delivery with key burn-specific barriers, including burn depth, eschar, infection, hypoxia, systemic inflammation, inhalation injury, grafting requirements, and temporal immune dysregulation across the systemic inflammatory response syndrome-to-compensatory anti-inflammatory response syndrome transition. We also discuss translational requirements that are often underemphasized in general wound-healing reviews, including dose scaling for large total body surface area burns, repeat application, compatibility with debridement and grafting, storage and thawing in burn centers, sterility, use in infected wounds, and whether local extracellular vesicle delivery can mitigate systemic dysfunction. Overall, microRNA-engineered extracellular vesicles are a versatile platform for burn wound repair; however, clinical translation remains speculative without large-animal, infected-burn, grafting, long-term scar, and human safety data.
引用
- Jin X, Wang J. MicroRNA-engineered extracellular vesicles for burn wound repair: burn-specific design and translational perspectives. J Burn Care Res. 2026. PMID: 42593741. doi:10.1093/jbcr/irag133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。